Trial Profile
A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in HIV-1 Seropositive Women During the Last Trimester of Pregnancy and Their Newborns
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Jul 2022
Price :
$35
*
At a glance
- Drugs CD4 IgG (Primary)
- Indications HIV infections
- Focus Adverse reactions; Pharmacokinetics
- 27 Oct 2014 New trial record